Risk assessment in PAH using quantitative CMR tricuspid regurgitation: relation to heart catheterization.
AIMS
Improved risk stratification is of value for decision making in pulmonary arterial hypertension (PAH). Right heart catheterization combined with quantitative tricuspid regurgitation (TR) by cardiovascular magnetic resonance (CMR) may provide this. The aims were to study: (i) to what extent quantitative TR is associated with event-free survival; (ii) how quantitative TR is related to known prognostic markers in PAH; and (iii) to what extent quantitative TR and right atrial pressure determine right atrial dilation.


METHODS AND RESULTS
Fifty patients (63 ± 17 years) with PAH referred for CMR were included. Volumes and pulmonary artery flow by CMR and pressure and vascular resistance by right heart catheterization were obtained. Composite outcome was lung transplantation or death. Four transplantations and 27 deaths occurred over a median of 2.7 years. A trend towards higher hazard ratio was shown for TR volume (TRV; 2.1, 95% CI 1.0-4.4) and TR fraction (TR%; 1.6, 95% CI 0.8-3.3) above median. TRV and TR% correlated with right ventricular (RV) end-diastolic (TRV r = 0.50; TR% r = 0.39) and end-systolic (TRV r = 0.35; TR% r = 0.30) volumes, pulmonary vascular resistance (TRV r = 0.28; TR% r = 0.43), N terminal pro brain natriuretic peptide (TRV r = 0.65; TR% r = 0.68), cardiac index (TRV r = -0.32; TR% r = -0.54), pulmonary artery stroke volume (TRV r = -0.32; TR% r = -0.58) and effective RV ejection fraction by pulmonary artery quantitative flow (TRV r = -0.56; TR% r = -0.69), but not RVEF. Both TR% and right atrial pressure determined right atrial volumes (r2  = 0.38; r2  = 0.48).


CONCLUSIONS
A clear trend towards worse outcome with larger TRV or TR% was shown; however, the number of events was insufficient for significant outcome differences. Prognostic value of quantitative TR should be investigated in a larger multicentre cohort. Effective RV ejection fraction may be considered an improved measure of RV function in PAH.
['Hedström|Erik|E|0000-0003-0041-9357', 'Bredfelt|Anna|A|', 'Rådegran|Göran|G|', 'Arheden|Håkan|H|', 'Ostenfeld|Ellen|E|']
D006328:Cardiac Catheterization D006801:Humans D006976:Hypertension, Pulmonary D009682:Magnetic Resonance Spectroscopy D000081029:Pulmonary Arterial Hypertension D018570:Risk Assessment D014262:Tricuspid Valve Insufficiency
Pulmonary arterial hypertension Right heart catheterization Outcome Cardiac magnetic resonance imaging Tricuspid valve regurgitation